Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Neurology: Clinical Practice Accelerator
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
    • UDDA Revision Series
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Neurology: Clinical Practice Accelerator
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
    • UDDA Revision Series
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

Share

June 10, 2003; 60 (11 suppl 4) Articles

Conversion to monotherapy

Clinical trials in patients with refractory partial seizures

Ahmad Beydoun, Ekrem Kutluay
First published June 10, 2003, DOI: https://doi.org/10.1212/WNL.60.11_suppl_4.S13
Ahmad Beydoun
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ekrem Kutluay
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Citation
Conversion to monotherapy
Clinical trials in patients with refractory partial seizures
Ahmad Beydoun, Ekrem Kutluay
Neurology Jun 2003, 60 (11 suppl 4) S13-S25; DOI: 10.1212/WNL.60.11_suppl_4.S13

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
1

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

Article Information

vol. 60 no. 11 suppl 4 S13-S25
DOI: 
https://doi.org/10.1212/WNL.60.11_suppl_4.S13
PubMed: 
12796517

Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published June 10, 2003.

Copyright & Usage: 
© 2003

Author Disclosures

    1. Ahmad Beydoun, MD and
    2. Ekrem Kutluay, MD
  1. Ahmad Beydoun, MD and
  2. Ekrem Kutluay, MD
  1. From the Department of Neurology, University of Michigan Health System, Ann Arbor, MI.
  1. Address correspondence and reprint requests to Dr. Ahmad Beydoun, Department of Neurology, University of Michigan Health System, UH1B300/0036, Ann Arbor, MI 48109.
View Full Text

Article usage

Article usage: June 2003 to July 2023

AbstractFullPdfSource
Jun 200324751Highwire
Jul 200324700Highwire
Aug 200317570Highwire
Sep 200322440Highwire
Oct 200315370Highwire
Nov 200321430Highwire
Dec 200311110Highwire
Jan 200416400Highwire
Feb 2004121110Highwire
Mar 200420670Highwire
Apr 200421260Highwire
May 200421270Highwire
Jun 200419310Highwire
Jul 200426430Highwire
Aug 200413430Highwire
Sep 200415260Highwire
Oct 200411250Highwire
Nov 200419350Highwire
Dec 200420230Highwire
Jan 200516370Highwire
Feb 200518400Highwire
Mar 200520230Highwire
Apr 200511190Highwire
May 200522390Highwire
Jun 200511260Highwire
Jul 20057110Highwire
Aug 20057140Highwire
Sep 20057450Highwire
Oct 200510370Highwire
Nov 200513360Highwire
Dec 200512240Highwire
Jan 20061040Highwire
Feb 20061490Highwire
Mar 200612120Highwire
Apr 20061550Highwire
May 2006510Highwire
Jun 2006490Highwire
Jul 20061040Highwire
Aug 20068100Highwire
Sep 200616110Highwire
Oct 20061020Highwire
Nov 2006610Highwire
Dec 2006650Highwire
Jan 20071150Highwire
Feb 2007320Highwire
Mar 20071430Highwire
Apr 2007840Highwire
May 20071150Highwire
Jun 20071060Highwire
Jul 20071430Highwire
Aug 20071330Highwire
Sep 20078100Highwire
Oct 20071190Highwire
Nov 20071420Highwire
Dec 20071030Highwire
Jan 2008710Highwire
Feb 20081030Highwire
Mar 20081100Highwire
Apr 20082420Highwire
May 2008910Highwire
Jun 20082620Highwire
Jul 20081740Highwire
Aug 20081030Highwire
Sep 2008650Highwire
Oct 2008820Highwire
Nov 20081300Highwire
Dec 20081100Highwire
Jan 2009910Highwire
Feb 2009870Highwire
Mar 20091620Highwire
Apr 2009700Highwire
May 20091520Highwire
Jun 2009800Highwire
Jul 2009620Highwire
Aug 2009720Highwire
Sep 2009950Highwire
Oct 20091410Highwire
Nov 20091210Highwire
Dec 2009500Highwire
Jan 20101300Highwire
Feb 20107170Highwire
Mar 20101210Highwire
Apr 20101240Highwire
May 2010620Highwire
Jun 2010610Highwire
Jul 2010800Highwire
Aug 2010420Highwire
Sep 2010600Highwire
Oct 2010700Highwire
Nov 2010310Highwire
Dec 20101400Highwire
Jan 20111050Highwire
Feb 2011610Highwire
Mar 2011810Highwire
Apr 20111070Highwire
May 201117130Highwire
Jun 2011400Highwire
Jul 2011600Highwire
Aug 2011920Highwire
Sep 2011620Highwire
Oct 2011730Highwire
Nov 2011510Highwire
Dec 20111000Highwire
Jan 2012800Highwire
Feb 20121700Highwire
Mar 2012830Highwire
Apr 20121000Highwire
May 20121130Highwire
Jun 20121230Highwire
Jul 2012410Highwire
Aug 2012300Highwire
Sep 2012820Highwire
Oct 2012700Highwire
Nov 20121000Highwire
Dec 20121310Highwire
Jan 2013400Highwire
Feb 2013500Highwire
Mar 20131010Highwire
Apr 20131500Highwire
May 20131660Highwire
Jun 20131800Highwire
Jul 20131100Highwire
Aug 20131300Highwire
Sep 20131100Highwire
Oct 20131210Highwire
Nov 20131210Highwire
Dec 20131200Highwire
Jan 20141200Highwire
Feb 20142000Highwire
Mar 20141810Highwire
Apr 20143310Highwire
May 20142410Highwire
Jun 20141310Highwire
Jul 20141820Highwire
Aug 2014600Highwire
Sep 2014810Highwire
Oct 2014940Highwire
Nov 2014600Highwire
Dec 2014820Highwire
Jan 2015800Highwire
Feb 20151100Highwire
Mar 2015600Highwire
Apr 2015700Highwire
May 2015500Highwire
Jun 20151500Highwire
Jul 20151500Highwire
Aug 2015600Highwire
Sep 2015810Highwire
Oct 2015710Highwire
Nov 2015200Highwire
Dec 2015730Highwire
Jan 2016610Highwire
Feb 2016300Highwire
Mar 2016100Highwire
Apr 2016510Highwire
May 2016430Highwire
Jun 20163500Highwire
Jul 2016500Highwire
Aug 2016700Highwire
Sep 2016400Highwire
Oct 20162910Highwire
Nov 2016800Highwire
Dec 2016500Highwire
Feb 2017500Highwire
Mar 20171000Highwire
Apr 2017300Highwire
May 2017400Highwire
Jun 2017600Highwire
Jul 2017700Highwire
Aug 2017400Highwire
Sep 2017600Highwire
Oct 20171600Highwire
Nov 2017900Highwire
Dec 2017510Highwire
Jan 2018610Highwire
Feb 2018120Highwire
Mar 2018200Highwire
Apr 2018200Highwire
May 2018510Highwire
Jun 20181850Highwire
Jul 2018700Highwire
Aug 2018800Highwire
Sep 20181800Highwire
Oct 20182040Highwire
Nov 2018400Highwire
Dec 2018410Highwire
Jan 2019310Highwire
Feb 2019500Highwire
Mar 20191100Highwire
Apr 2019810Highwire
May 2019710Highwire
Jun 20191100Highwire
Jul 2019720Highwire
Aug 2019300Highwire
Sep 2019910Highwire
Oct 2019900Highwire
Nov 2019400Highwire
Dec 2019100Highwire
Jan 2020200Highwire
Feb 2020610Highwire
Mar 20202400Highwire
May 2020400Highwire
Jun 2020300Highwire
Jul 2020110Highwire
Aug 2020300Highwire
Sep 2020200Highwire
Oct 20202000Highwire
Nov 20202610Highwire
Dec 2020910Highwire
Jan 2021320Highwire
Feb 2021100Highwire
Mar 2021700Highwire
Apr 2021400Highwire
May 2021600Highwire
Jun 20212040Highwire
Jul 2021700Highwire
Aug 20211800Highwire
Sep 2021700Highwire
Oct 20211700Highwire
Nov 2021500Highwire
Dec 2021800Highwire
Jan 2022200Highwire
Feb 20221110Highwire
Mar 20223200Highwire
Apr 20221100Highwire
May 2022700Highwire
Jun 2022600Highwire
Jul 2022600Highwire
Aug 20221700Highwire
Sep 2022830Highwire
Oct 2022100Highwire
Nov 2022600Highwire
Dec 2022500Highwire
Jan 2023500Highwire
Feb 2023400Highwire
Mar 2023900Highwire
Apr 2023310Highwire
May 2023200Highwire
Jun 20231110Highwire
Jul 2023700Highwire

Cited By...

  • 22 Citations
  • Google Scholar

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Abstract
    • Historical perspectives on the design of conversion-to-monotherapy trials.
    • Outpatient conversion to monotherapy trials.
    • Results of outpatient conversion to monotherapy trials.
    • Advantages and shortcomings of outpatient conversion to monotherapy trials.
    • Presurgical conversion to monotherapy trials.
    • Results of presurgical conversion to monotherapy trials.
    • Advantages and shortcomings of presurgical conversion to monotherapy trials.
    • Conclusions.
    • Footnotes
    • References
  • Figures & Data
  • Info & Disclosures
Advertisement

Association Between Fluctuations in Blood Lipid Levels Over Time With Incident Alzheimer Disease and Alzheimer Disease–Related Dementias

Dr. Sevil Yaşar and Dr. Behnam Sabayan

► Watch

Related Articles

  • No related articles found.

Alert Me

  • Alert me when eletters are published

Recommended articles

  • Articles
    Oxcarbazepine adjunctive therapy in infants and young children with partial seizures
    J. E. Piña-Garza, R. Espinoza, D. Nordli et al.
    Neurology, November 07, 2005
  • Articles
    Oxcarbazepine monotherapy for partial-onset seizures
    A multicenter, double-blind, clinical trial
    A. Beydoun, R.C. Sachdeo, W.E. Rosenfeld et al.
    Neurology, June 27, 2000
  • Articles
    Monotherapy clinical trial design
    Rajesh Sachdeo et al.
    Neurology, December 10, 2007
  • Articles
    Oxcarbazepine (Trileptal) as monotherapy in patients with partial seizures
    R. Sachdeo, A. Beydoun, S. Schachter et al.
    Neurology, September 11, 2001
Neurology: 101 (14)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise